Peter Marckmann

Summary

Affiliation: University of Copenhagen
Country: Denmark

Publications

  1. doi request reprint Nephrogenic systemic fibrosis: clinical picture and treatment
    Peter Marckmann
    Department of Nephrology, Odense University Hospital, Soender Boulevard 29, DK 4000 Odense, Denmark
    Radiol Clin North Am 47:833-40, vi. 2009
  2. doi request reprint Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D
    Peter Marckmann
    Clinical Research Unit, Department of Nephrology, Odense University Hospital, Odense, Denmark
    Nephrol Dial Transplant 27:3523-31. 2012
  3. ncbi request reprint Clinical manifestation of gadodiamide-related nephrogenic systemic fibrosis
    P Marckmann
    Department of Nephrology, Copenhagen University Hospital Herlev, Denmark
    Clin Nephrol 69:161-8. 2008
  4. doi request reprint Possibly enhanced Gd excretion in dialysate, but no major clinical benefit of 3-5 months of treatment with sodium thiosulfate in late stages of nephrogenic systemic fibrosis
    Peter Marckmann
    Department of Nephrology, Copenhagen University Hospital Herlev, Herlev Ringvej 75, DK 2730 Herlev, Denmark
    Nephrol Dial Transplant 23:3280-2. 2008
  5. doi request reprint An epidemic outbreak of nephrogenic systemic fibrosis in a Danish hospital
    Peter Marckmann
    Department of Nephrology, Copenhagen University Hospital Herlev, Herlev Ringvej 75, DK 2730 Herlev, Denmark
    Eur J Radiol 66:187-90. 2008
  6. doi request reprint Nephrogenic systemic fibrosis: epidemiology update
    Peter Marckmann
    Department of Nephrology, Copenhagen University Hospital Herlev, Herlev, Denmark
    Curr Opin Nephrol Hypertens 17:315-9. 2008
  7. ncbi request reprint Case-control study of gadodiamide-related nephrogenic systemic fibrosis
    Peter Marckmann
    Department of Nephrology, Herlev Hospital, DK 2730 Herlev, Denmark
    Nephrol Dial Transplant 22:3174-8. 2007
  8. ncbi request reprint Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging
    Peter Marckmann
    Department of Nephrology, Copenhagen University Hospital at Herlev, DK 2730 Herlev, Denmark
    J Am Soc Nephrol 17:2359-62. 2006
  9. ncbi request reprint [Dietary protein restriction and chronic renal failure]
    Peter Marckmann
    Nefrologisk Afdeling B, Amtssygehuset i Herlev
    Ugeskr Laeger 165:4101-3. 2003
  10. ncbi request reprint Nephrogenic systemic fibrosis: a serious iatrogenic disease of renal failure patients
    Misbah Khurram
    Department of Nephrology, Copenhagen University Hospital Herlev, Herlev, Denmark
    Scand J Urol Nephrol 41:565-6. 2007

Collaborators

Detail Information

Publications24

  1. doi request reprint Nephrogenic systemic fibrosis: clinical picture and treatment
    Peter Marckmann
    Department of Nephrology, Odense University Hospital, Soender Boulevard 29, DK 4000 Odense, Denmark
    Radiol Clin North Am 47:833-40, vi. 2009
    ..Spontaneous remission of NSF symptoms may occur with recovery of renal function after an episode of acute renal failure, or with kidney transplantation of chronic renal failure patients...
  2. doi request reprint Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D
    Peter Marckmann
    Clinical Research Unit, Department of Nephrology, Odense University Hospital, Odense, Denmark
    Nephrol Dial Transplant 27:3523-31. 2012
    ..Hypovitaminosis D is common in chronic kidney disease (CKD). Effects of 25-hydroxyvitamin D replenishment in CKD are not well described...
  3. ncbi request reprint Clinical manifestation of gadodiamide-related nephrogenic systemic fibrosis
    P Marckmann
    Department of Nephrology, Copenhagen University Hospital Herlev, Denmark
    Clin Nephrol 69:161-8. 2008
    ..To further characterize the clinical signs and symptoms of nephrogenic systemic fibrosis, a new and serious disease affecting renal failure patients and caused by some Gd-containing contrast agents, including gadodiamide...
  4. doi request reprint Possibly enhanced Gd excretion in dialysate, but no major clinical benefit of 3-5 months of treatment with sodium thiosulfate in late stages of nephrogenic systemic fibrosis
    Peter Marckmann
    Department of Nephrology, Copenhagen University Hospital Herlev, Herlev Ringvej 75, DK 2730 Herlev, Denmark
    Nephrol Dial Transplant 23:3280-2. 2008
    ..Gd-related nephrogenic systemic fibrosis was successfully treated with intravenous sodium thiosulfate according to a recent case report...
  5. doi request reprint An epidemic outbreak of nephrogenic systemic fibrosis in a Danish hospital
    Peter Marckmann
    Department of Nephrology, Copenhagen University Hospital Herlev, Herlev Ringvej 75, DK 2730 Herlev, Denmark
    Eur J Radiol 66:187-90. 2008
    ..Unfortunately, there is no proven curative treatment. It is therefore essential that future cases of nephrogenic systemic fibrosis are prevented...
  6. doi request reprint Nephrogenic systemic fibrosis: epidemiology update
    Peter Marckmann
    Department of Nephrology, Copenhagen University Hospital Herlev, Herlev, Denmark
    Curr Opin Nephrol Hypertens 17:315-9. 2008
    ..The aim of this article is to outline the history of nephrogenic systemic fibrosis, a new and serious disease of patients with renal failure, and to give an update on its aetiology and prevalence...
  7. ncbi request reprint Case-control study of gadodiamide-related nephrogenic systemic fibrosis
    Peter Marckmann
    Department of Nephrology, Herlev Hospital, DK 2730 Herlev, Denmark
    Nephrol Dial Transplant 22:3174-8. 2007
    ..Most reported cases were associated with one particular agent, gadodiamide. Yet, unidentified cofactors might explain why only a minority of renal failure patients exposed to gadodiamide develop nephrogenic systemic fibrosis...
  8. ncbi request reprint Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging
    Peter Marckmann
    Department of Nephrology, Copenhagen University Hospital at Herlev, DK 2730 Herlev, Denmark
    J Am Soc Nephrol 17:2359-62. 2006
    ..No other exposure/event than gadodiamide that was common to more than a minority of the patients could be identified. These findings indicate that gadodiamide plays a causative role in nephrogenic systemic fibrosis...
  9. ncbi request reprint [Dietary protein restriction and chronic renal failure]
    Peter Marckmann
    Nefrologisk Afdeling B, Amtssygehuset i Herlev
    Ugeskr Laeger 165:4101-3. 2003
  10. ncbi request reprint Nephrogenic systemic fibrosis: a serious iatrogenic disease of renal failure patients
    Misbah Khurram
    Department of Nephrology, Copenhagen University Hospital Herlev, Herlev, Denmark
    Scand J Urol Nephrol 41:565-6. 2007
    ..It has been demonstrated in recent studies that NSF can be caused by some gadolinium-containing MRI contrast agents. In this report we present one of a total of 26 cases of gadodiamide-related NSF from our hospital...
  11. doi request reprint Impact of vitamin D status and obesity on C-reactive protein in kidney-transplant patients
    Bettina Ewers
    Department of Nephrology, Copenhagen University Hospital Herlev, Denmark
    J Ren Nutr 18:294-300. 2008
    ..We examined whether vitamin D status and obesity are associated with low-grade systemic inflammation, as assessed by serum concentrations of C-reactive protein (CRP) in an adult population of kidney-transplant patients...
  12. doi request reprint Extracellular Gd-CA: differences in prevalence of NSF
    Henrik S Thomsen
    Department of Diagnostic Radiology, Copenhagen University Hospital, Herlev, Herlev Ringvej 75, DK 2730 Herlev, Denmark
    Eur J Radiol 66:180-3. 2008
    ..No report of NSF after the most stable agents has been reported in the peer-reviewed literature documenting that there is a difference between the various agents regarding triggering NSF...
  13. doi request reprint Vitamin D status in children and adolescents with kidney transplants
    Louise Aarup Brodersen
    Department of Nephrology, Odense University Hospital, Odense, Denmark
    Pediatr Transplant 15:384-9. 2011
    ..Our data suggest that it is warranted to monitor vitamin D status of kidney-transplanted children and adolescents and indicate that correction of hypovitaminosis D might have favorable effects on calcium-phosphate metabolism...
  14. doi request reprint High prevalence of nephrogenic systemic fibrosis in chronic renal failure patients exposed to gadodiamide, a gadolinium-containing magnetic resonance contrast agent
    Casper Rydahl
    Department of Nephrology, Copenhagen University Hospital Herlev, Herlev, Denmark
    Invest Radiol 43:141-4. 2008
    ..It may be caused by some gadolinium (Gd)-containing contrast agents, including gadodiamide. The study aimed at estimating the prevalence of NSF after gadodiamide exposure for patients with chronic kidney disease (CKD)...
  15. pmc Plasma concentrations of extracellular matrix protein fibulin-1 are related to cardiovascular risk markers in chronic kidney disease and diabetes
    Alexandra Scholze
    Clinical Research Unit, Department of Nephrology, Odense University Hospital, Odense, Denmark
    Cardiovasc Diabetol 12:6. 2013
    ..Fibulin-1 is one of a few extracellular matrix proteins present in blood in high concentrations. We aimed to define the relationship between plasma fibulin-1 levels and risk markers of cardiovascular disease...
  16. doi request reprint Vitamin d and stage 5 chronic kidney disease: a new paradigm?
    James Goya Heaf
    Department of Nephrology, University of Copenhagen Herlev Hospital, Herlev, Denmark
    Semin Dial 25:50-8. 2012
    ..A randomized controlled trial to test this hypothesis is warranted...
  17. doi request reprint MRI contrast media are used to improve visualization of abnormal structures or lesions in various parts of the body. Introduction
    Henrik S Thomsen
    Department of Diagnostic Radiology, Copenhagen University Hospital, Herlev, Herlev Ringvej 75, DK 2730 Herlev, Denmark
    Eur J Radiol 66:153-9. 2008
    ..The prevention of NSF must be given high priority, but it should not lead to a denial of a well-justified, enhanced MRI examination with a stable agent...
  18. ncbi request reprint [Kidney function and immunosuppression of kidney-transplanted patients]
    Anne Mette Frederiksen
    Herlev Hospital, Nefrologisk afdeling, Herlev
    Ugeskr Laeger 170:1658-62. 2008
    ....
  19. ncbi request reprint Vitamin D status in kidney transplant patients: need for intensified routine supplementation
    Bettina Ewers
    Department of Nephrology, Copenhagen University Hospital Herlev, Herlev, Denmark
    Am J Clin Nutr 87:431-7. 2008
    ..A high prevalence of vitamin D insufficiency has been found in the general population and in patients with chronic kidney disease...
  20. ncbi request reprint Cancer rates after kidney transplantation
    Ulrik Sodemann
    Department of Nephrology, Odense University Hospital, 5000 Odense C, Denmark
    Dan Med Bull 58:A4342. 2011
    ....
  21. pmc Nephrogenic systemic fibrosis (NSF): a late adverse reaction to some of the gadolinium based contrast agents
    Henrik S Thomsen
    Department of Diagnostic Radiology, Copenhagen University Hospital, Herlev, Denmark
    Cancer Imaging 7:130-7. 2007
    ..The fear of nephrogenic systemic fibrosis should not lead to a denial of a well indicated enhanced magnetic resonance imaging examination...
  22. doi request reprint Update on nephrogenic systemic fibrosis
    Henrik S Thomsen
    Department of Diagnostic Radiology, Copenhagen University Hospital Herlev, Herlev, Denmark
    Magn Reson Imaging Clin N Am 16:551-60, vii. 2008
    ..73 m(2), including those on dialysis. The fear of NSF, however, should not lead to an enhanced MR imaging examination being denied when there is a good clinical indication to give a gadolinium-based contrast agent...
  23. ncbi request reprint [A scientific evaluation of the "alternative" food pyramid]
    Bjørn Richelsen
    Ernaeringsrådet, Søborg
    Ugeskr Laeger 167:927-31. 2005
  24. ncbi request reprint A high fat meal activates blood coagulation factor VII in rats
    Aage K Olsen
    Department for Thrombosis Research, Ribe County Hospital, University of Southern Denmark, Esbjerg, Denmark
    J Nutr 132:347-50. 2002
    ..Glucose administration did not affect any variable. We conclude that the LEW/Mol rat is a promising model for use in future studies of thrombotic effects of dietary FVII activation...